Citalopram HBR 20 MG tablet 500S
Ended Awarded
- Contract number
- SPE2DB25FY8BQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,797
Award facts
- Contract value 100% obligated
- $20,796.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Citalopram HBR 20 mg tablets (500 units) with a ceiling value of $20,796.79. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for completion by July 21, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.999 billion prime vendor agreement through December 2026 that serves as the primary vehicle for pharmaceutical and medical supply distribution to military healthcare systems globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting Defense Health Agency and U.S. Coast Guard medical supply needs. The company maintains an extensive portfolio of federal contract awards with the DLA, covering a comprehensive range of pharmaceutical products including specialty medications, vaccines, and medical devices across multiple therapeutic domains. All reviewed contract awards with AmerisourceBergen have been non-set-aside and competitively awarded, demonstrating the company's capability to meet stringent federal procurement standards and support military healthcare operations both domestically and globally.
Quick answers
Who was awarded contract SPE2DB25FY8BQ?
SPE2DB25FY8BQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 18, 2025.
How much is contract SPE2DB25FY8BQ worth?
The government has obligated $20,797 on SPE2DB25FY8BQ.
Is contract SPE2DB25FY8BQ an order under another contract?
Yes. SPE2DB25FY8BQ is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY8BQ competed?
The extent of competition for SPE2DB25FY8BQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award